Synutra Internationa (SYUT) 3.70 $SYUT Synutra Reports

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Synutra Internationa (SYUT) 3.70 $SYUT

Synutra Reports Fourth Quarter and Full Year Fiscal 2016 Financial Results
PR Newswire - Mon Jun 13, 6:30AM CDT
Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company", which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for the fourth quarter and full year of fiscal 2016 ended March 31, 2016.
SYUT: 3.70 (+0.30)

Synutra to Announce Fourth Quarter and Full Year Fiscal 2016 Financial Results
PR Newswire - Wed Jun 01, 7:30AM CDT
Synutra International, Inc. (NASDAQ: SYUT) ("Synutra" or the "Company", which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced that it plans to release its financial results for the fourth quarter and full year of fiscal 2016 on Monday, June 13, 2016 before the US market open.
SYUT: 3.70 (+0.30)

Synutra posts 3Q profit
Automated Insights - Fri Feb 05, 5:39AM CST
ROCKVILLE, Md. (AP) _ Synutra International Inc. (SYUT) on Friday reported fiscal third-quarter profit of $12 million.
SYUT: 3.70 (+0.30)

Synutra Special Committee Engages Independent Financial Advisor and Legal Counsel in connection with "Going Private" Proposal
PR Newswire - Fri Feb 05, 5:30AM CST
Synutra International, Inc. (Nasdaq: SYUT) ("Synutra" or the "Company", which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that the special committee of its board of directors (the "Board", which is composed entirely of independent directors (the "Special Committee", has retained Houlihan Lokey Capital, Inc. as the Special Committee's independent financial advisor and Cleary Gottlieb Steen & Hamilton LLP as its U.S. legal counsel in connection with its review and evaluation of the non-binding proposal letter dated January 14, 2016, as revised on January 30, 2016, from Mr. Liang Zhang, the chairman of the Board and chief executive officer of Synutra ("Mr. Zhang", and an affiliated entity of Mr. Zhang (together with Mr. Zhang, the "Buyer Group", to acquire all of the outstanding common stock of the Company not already owned by the Buyer Group in a "going-private" transaction (the "Proposal". In addition, the Company has retained Wilson Sonsini Goodrich & Rosati as its U.S. legal counsel in connection with the potential "going-private" transaction contemplated by the Proposal.
SYUT: 3.70 (+0.30)

Synutra Reports Third Quarter Fiscal 2016 Financial Results
PR Newswire - Fri Feb 05, 5:30AM CST
Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company", which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for the third quarter of fiscal 2016 ended December 31, 2015.
SYUT: 3.70 (+0.30)

Synutra Announces Receipt of Revised Non-Binding "Going Private" Proposal
PR Newswire - Tue Feb 02, 8:37AM CST
Synutra International, Inc. (Nasdaq: SYUT) ("Synutra" or the "Company", which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that the special committee of its board of directors (the "Board", which is composed entirely of independent directors (the "Special Committee", has received a letter (the "Letter", dated January 30, 2016, from Mr. Liang Zhang, the chairman of the Board and chief executive officer of Synutra ("Mr. Zhang", and an affiliated entity of Mr. Zhang (together with Mr. Zhang, the "Buyer Group", reaffirming the Buyer Group's interest in pursuing a "going-private" transaction (the "Transaction" to acquire all of the outstanding common stock (the "Shares" of the Company not already owned by the Buyer Group for US$5.91 in cash per Share. The Letter further provides that (i) the Buyer Group will not proceed with the Transaction unless it is approved by the Special Committee, taking into account the advice of its independent advisors and (ii) the Transaction will be subject to a non-waivable condition requiring the approval by holders of a majority of the Shares of the Company not beneficially owned by the Buyer Group. The Company previously announced receipt of the non-binding proposal on January 15, 2016. A copy of the Letter is attached as Annex A to this press release.
SYUT: 3.70 (+0.30)

/C O R R E C T I O N -- Synutra International, Inc./
PR Newswire - Tue Feb 02, 8:18AM CST
In the news release, Synutra to Announce Third Quarter Fiscal 2016 Financial Results, issued 02-Feb-2016 by Synutra International, Inc. over PR Newswire, we are advised by the company that the first paragraph, first sentence, should read "[...] plans to release its financial results for the third quarter of fiscal 2016 on Friday, February 5, 2016 before the US market open." rather than "[...] plans to release its financial results for the third quarter of fiscal 2016 on Thursday, February 4, 2016 after the market closes." as originally issued inadvertently. The complete, corrected release follows:
SYUT: 3.70 (+0.30)

Synutra to Announce Third Quarter Fiscal 2016 Financial Results
PR Newswire - Tue Feb 02, 7:30AM CST
Synutra International, Inc. (NASDAQ: SYUT) ("Synutra" or the "Company", which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced that it plans to release its financial results for the third quarter of fiscal 2016 on Thursday, February 4, 2016 after the market closes.
SYUT: 3.70 (+0.30)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synutra International, Inc. of an Investigation Concerning the Proposed Sale of the Company to Its CEO
BusinessWire - Mon Jan 25, 4:53PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
SYUT: 3.70 (+0.30)

Lifshitz & Miller Law Firm Announces Investigation of GoPro Inc., Iconix Brand Group, Inland Real Estate Corporation, Nobilis Health Corp., Sarepta Therapeutics, Inc., Synutra International Inc., and Wilshire Bancorp Inc.
PR Newswire - Fri Jan 22, 6:47PM CST
GoPro Inc. (GPRO)
IRC: 10.61 (+0.02), ICON: 6.84 (+0.22), GPRO: 10.97 (+0.20), WIBC: 10.75 (+0.33), HLTH: 2.35 (+0.09), SRPT: 22.62 (+1.70), SYUT: 3.70 (+0.30)

SYNUTRA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Synutra International, Inc. (SYUT) Over the Proposed Sale of the Company to Its CEO
BusinessWire - Fri Jan 22, 4:21PM CST
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synutra International, Inc. ("Synutra" or the "Company" (NasdaqGS:SYUT) for potential breaches of fiduciary duties in connection with the sale of the Company to Mr. Liang Zhang, the Company's Chief Executive Officer and Chairman of the Board of Directors, for approximately $338 million.
SYUT: 3.70 (+0.30)

Synutra Announces Appointment of New Director and Formation of Special Committee
PR Newswire - Fri Jan 22, 3:15PM CST
Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company", which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced the appointment of a new director and the formation of an independent special committee.
SYUT: 3.70 (+0.30)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synutra International, Inc. of an Investigation Regarding the Proposed Sale of the Company to its CEO
BusinessWire - Thu Jan 21, 12:11PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
SYUT: 3.70 (+0.30)

Gardy & Notis, LLP Investigates the Proposed Cashout of Synutra International, Inc. (NASDAQ: SYUT) Stockholders by Chairman and Controlling Shareholder Liang Zhang
PR Newswire - Wed Jan 20, 4:03PM CST
Gardy & Notis, LLP is investigating potential claims on behalf of investors in Synutra International, Inc. (NASDAQ: SYUT), concerning the going private proposal of Synutra by Mr. Liang Zhang, the Company's Chief Executive Officer, Chairman of the Board of Directors, and controlling shareholder and an affiliated entity of Mr. Zhang, whereby Synutra stockholders would be cashed out of their investment in exchange for $5.91 per share in cash for each Synutra share they own. Synutra stockholders seeking more information about this acquisition may contact Mark C. Gardy at (212) 905-0509 or mgardy@gardylaw.com.
SYUT: 3.70 (+0.30)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synutra International, Inc. of an Investigation Concerning the Proposed Sale of the Company to its CEO -- SYUT
PR Newswire - Tue Jan 19, 12:35PM CST
The following statement is being issued by Levi & Korsinsky, LLP:
SYUT: 3.70 (+0.30)

Company News for January 19, 2016
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 9:10AM CST
Companies in the News are: WYNN,PRO,GS,SYUT
GS: 150.38 (+3.38), WYNN: 89.75 (+0.79), SYUT: 3.70 (+0.30), PRO: 17.34 (+0.28)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synutra International, Inc. of an Investigation Concerning the Proposed Sale of the Company to its CEO - SYUT
ACCESSWIRE - Mon Jan 18, 11:15AM CST
NEW YORK, NY / ACCESSWIRE / January 18, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
SYUT: 3.70 (+0.30)

SYNUTRA ALERT - National Securities Law Firm Seeks Higher Price for Synutra Shareholders, and Encourages Shareholders to Contact Law Firm for More Information
PR Newswire - Sat Jan 16, 8:54AM CST
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the sale of Synutra International, Inc. (NASDAQ: SYUT) ("Synutra" or the "Company" on behalf of its shareholders. Synutra announced that it has received a non-binding proposal letter from Mr. Liang Zhang, Chairman and Chief Executive Officer of Synutra, proposing a "going-private" transaction to acquire all of the outstanding common stock of Synutra not already owned by him for $5.91 in cash per share.
SYUT: 3.70 (+0.30)

EQUITY ALERT: Rosen Law Firm Announces Investigation of Synutra International, Inc. Concerning the Proposed Sale to its Chairman and CEO - SYUT
BusinessWire - Fri Jan 15, 3:47PM CST
Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Synutra International Inc. (NASDAQ:SYUT) for possible breaches of fiduciary duty and other violations of law in connection with a going private proposal from its Chairman and Chief Executive Officer Liang Zhang and an affiliated entity of his (collectively, the "Buyer Group".
SYUT: 3.70 (+0.30)

Synutra Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
PR Newswire - Fri Jan 15, 7:30AM CST
Synutra International, Inc. (Nasdaq: SYUT), ("Synutra" or the "Company", which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that its board of directors (the "Board" has received a non-binding proposal letter, dated January 14, 2016, from Mr. Liang Zhang ("Mr. Zhang", Chairman and chief executive officer of Synutra, and an affiliated entity of his (together with Mr. Zhang, the "Buyer Group", proposing a "going-private" transaction (the "Transaction" to acquire all of the outstanding common stock (the "Shares" of the Company not already owned by the Buyer Group for US$5.91 in cash per Share, subject to certain conditions, which represents a premium of approximately 63% to the closing price of the Company's Shares on January 13, 2016, and a premium of approximately 30% to the volume-weighted average closing price of the Company's Shares during the last 20 trading days.
SYUT: 3.70 (+0.30)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading